Onconetix, Inc.
ONCO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $3 | $1 | $7 |
| - Cash | $1 | $0 | $2 | $1 |
| + Debt | $0 | $9 | $9 | $9 |
| Enterprise Value | $4 | $11 | $9 | $16 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | 185.1% | 4.8% | -85.7% | – |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | 88.6% | 66.2% | 45.1% | 92.7% |
| EBITDA | -$8 | -$2 | -$8 | -$30 |
| % Margin | -2,792.8% | -2,014.8% | -8,184.1% | -4,212% |
| Net Income | -$9 | -$2 | -$9 | -$29 |
| % Margin | -2,892.7% | -2,227.8% | -8,408.8% | -4,134.7% |
| EPS Diluted | -6.25 | -4.76 | -1,802 | -17.38 |
| % Growth | -31.3% | 99.7% | -10,268.2% | – |
| Operating Cash Flow | -$3 | -$1 | -$2 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$3 | -$1 | -$2 | -$1 |